Kaitlyn D’Onofrio

DocwireNews

<a href="https://www.nature.com/articles/s41467-019-12527-5#Sec6">A group of researchers</a> have developed a <a href="https://www.docwirenews.com/docwire-pick/a-simple-blood-test-for-melanoma-detection/">blood test</a> that may be able to more quickly diagnose patients with brain cancer, thereby allowing them to seek treatment earlier and possibly increasing their chance for survival.&ldquo;This is the first publication of data from our clinical feasibility study and it is the first demonstration that our blood test works in the clinic,&rdquo; said lead study author Dr. Matthew J. Baker, reader in the University of Strathclyde&rsquo;s Department of Pure and Applied Chemistry and chief scientific officer of ClinSpec Diagnostics, <a href="https://www.eurekalert.org/pub_releases/2019-10/uos-btc100919.php">in a press release</a>. &ldquo;Earlier detection of brain [tumors] in the diagnostic pathway brings the potential to significantly improve patient quality of life and survival, whilst also providing savings to the health services.&rdquo;Making a timely diagnosis of brain tumors is difficult because symptoms often mirror those of much less serious conditions, with one of the main symptoms being headache, the study authors note. By the time they are diagnosed, most patients have already had several visits with their general practitioner.In this new method, the researchers analyzed blood serum using attenuated total reflectance&ndash;Fourier transform infrared (ATR-FTIR) spectroscopy. The serum sample is deposited onto the surface of an internal reflection element (IRE). Infrared (IR) light then enters the IRE, and this internal reflection forms an evanescent wave at the IRE-sample interface. &ldquo;It is this wave that interrogates the samples at a defined penetration depth (calculable dependent upon refractive indices of the IRE and sample, the wavelength of IR beam, and the angle of incidence),&rdquo; the authors described.The drawback of IRE is that it is typically an expensive, inflexible option that does not allow for batch processing. The researchers therefore proposed that silicone IREs would be a viable option.&ldquo;The technical considerations inherent in applying this test in real-time in the clinic have been explored in great detail, including the examination of sample, preparation, and an investigation into the mechanisms of serum deposition patterns that may influence the spectral response. The integration of the test into a clinical pathway has also been assessed,&rdquo; the study authors wrote.This new method is not intended to be an absolute diagnostic tool, but rather one tool that general practitioners can use in guiding their decision of whether to refer a patient to a specialist.The researchers tested their technology in a retrospective cohort with good outcomes: &ldquo;On a per patient basis, and averaged over 51 randomised training and test set splits, the sensitivity and specificity of the approach computed for the test set is 93.2% and 92.0% respectively, indicating potential to detect both cancer and control patients effectively.&rdquo;They therefore employed the test in a prospective cohort, which included 104 test patients; here, the reported sensitivity and specificity were 83.3% and 87.0%, respectively&mdash;which, while lower than the retrospective outcomes, is still higher than the cost-effectiveness thresholds.Study partner Dr. Paul Brennan, senior clinical lecturer and consultant neurosurgeon at the University of Edinburgh, said, &ldquo;With this new test, we have shown that we can help doctors quickly identify which patients with these non-specific symptoms should be [prioritized] for urgent brain imaging. This means a more rapid diagnosis for people with a brain [tumor], and quicker access to treatment.&rdquo;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Blood Test May Eventually Speed up Brain Cancer Diagnosis

Oncology

A group of researchers have developed a blood test that may be able to more quickly diagnose patients with brain cancer, thereby allowing them to seek treatment earlier and ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe